• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® BRAHAMS PROCALCITONIN; VIDAS® BRAHAMS PCT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® BRAHAMS PROCALCITONIN; VIDAS® BRAHAMS PCT Back to Search Results
Catalog Number 30450-01
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
A customer in the united states reported that they obtained a false low result for their cap survey sample, using the vidas® brahams procalcitonin (pct) assay, lot 1006974220.The customer stated the qc was within range using kit controls.S1 rfv was 2077 (range 1748 - 3122; mean 2435); s2 rfv 424 (range 292 - 521; mean 406.5); c1 18.10 ng/ml (range 12.95 - 20.23ng/ml); c2 1.86 ng/ml (range 1.33 - 2.15 ng/ml); qc result of 5.64 ng/ml ( expected value range was 6.21 - 8.56 ng/ml).According to the cap survey report: pct-01 : customer s result 5.64 ng/ml peer group mean = 7.386 ng/ml range [6.21-8.56] => out of range too low; pct-02 : customer s result < 0.05 ng/ml not evaluated; pct-03 : customer s result 1.96 ng/ml peer group mean = 2.240 ng/ml range [1.86-2.67].A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for a false low result for a cap survey sample, using the vidas® brahms procalcitonin (pct) assay, lot: 1006974220.Customer's material: no customer's material was received for investigation.Quality control records: no capa nor non conformity linked to the customer's issue was recorded on vidas brahms procalcitonin reference: (b)(4), lot: 1006974220 / 191127-0.Analysis of the batch history records showed no anomaly during the manufacturing, control and packaging processes on lot vidas brahms procalcitonin reference: (b)(4), lot: 1006974220 / 191127-0.Study of internal samples control charts : complaint laboratory observed 4 internal sera (targets 1.22 g/l ; 7.72 g/l ; 10.7 g/l; 0.30 g/l) on 9 lots of vidas brahms procalcitonin including customer's lot: (191127-0).All results were within specifications and the customer's lot was in the trend of the other lots.Complaint analysis : no other complaint was registered on the same external quality control cap survey pct a01.Tests performed in complaint's laboratory: complaint laboratory tested 4 internal samples (same as above) on retain kit vidas brahms procalcitonin reference: (b)(4), lot: 1006974220 / 191127-0.Results were within specifications and close to the values obtained before batch release.There was no drift of the batch since its release.Conclusion: customer's issue was not reproduced.According to all the data above, vidas brahms procalcitonin reference: (b)(4), lot: 1006974220 / 191127-0 performed as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® BRAHAMS PROCALCITONIN
Type of Device
VIDAS® BRAHAMS PCT
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280,
FR 
MDR Report Key8669246
MDR Text Key213479409
Report Number8020790-2019-00031
Device Sequence Number1
Product Code PRI
UDI-Device Identifier03573026223601
UDI-Public03573026223601
Combination Product (y/n)N
PMA/PMN Number
K071146
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 09/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/27/2019
Device Catalogue Number30450-01
Device Lot Number1006974220
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/06/2019
Initial Date FDA Received06/04/2019
Supplement Dates Manufacturer Received08/14/2019
Supplement Dates FDA Received09/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-